Send me more jobs like this

Executive -Operational Excellence/ Business Excellence

Keywords / Skills : Green Belt, Six Sigma, Yellow Belt, Opex, Operational excellence

2 - 6 years
Posted: 2019-05-16

Nationality
India
Industry
Pharmaceutical
Function
Pharmaceutical/Biotechnology
Role
Operations Director
Education
Bachelor Of Technology (BTech
BE)
Stream:
Chemical
Posted On
16th May 2019
Job Description
Greetings from Lupin !!!


We have opening for Executive/ Sr. Executive - Operational Excellence.

Please find the below JD:

Industry : Pharma

Location : Tarapur (Mumbai)

Education: BE (Chemical) with 60% Marks.

Lead lean and Six sigma projects to deliver targeted result.

Support other project leaders in their LSS project

Support Manpower Optimization activity.

Benchmarking best practices from intra Tarapur plant and Other API plant.

Cloning of project to and from other plant.

Delivering training locally.

Building an efficient team and maintaining strength, harmony, a high degree of

moral, discipline and technical expertise in the team.

Ensuring carrying out operation as per cGMP, safety norms and SOP's.

Periodically carrying out reviews and revision of SOP's as per needed.

experience In :

Green Belt Projects.

Industrial Engineering,

Lean Manufacturing,

Process Excellence,

Operational Excellence,

Safety Mgmt,

Continuous Improvement,

Six Sigma.

Interested candidate can apply through Naukri or share resume on :

[HIDDEN TEXT]



About Company

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded and generic formulations, biosimilar products and APIs globally. The Company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership position in the Anti-TB segment.


Lupin is the 8th largest generics pharmaceutical company by revenues (31st Dec 2018, Bloomberg LTM). The Company is the 3rd largest pharmaceutical player in the US by prescriptions (IQVIA MAT Mar 2019); 3rd largest Indian pharmaceutical company by global revenues (31st Dec 2018, Bloomberg LTM); 5th largest company in the Indian Pharmaceutical Market and 6th largest generic pharmaceutical player in Japan (IQVIA MAT Mar 2019).

For the financial year ended 31st March 2019, Lupin’s Consolidated sales and Net profits before exceptional items were at INR 163,694 million (USD 2.34 billion) and INR 9,466 million (USD 136 million) respectively. Please visit http://www.lupin.com for more information
Similar Jobs
View All Similar Jobs
Walkin for you